期刊文献+

浅谈加强我国药品上市后研究 被引量:4

Discuss on Strengthening Our Study of Post-marketing Drug
暂未订购
导出
摘要 药品上市后研究已经成为社会各界广泛关注的焦点。通过介绍药品上市前研究的局限性,药品使用的多样性、复杂性及不合理性,以及国内、外药品上市后研究分析现状,以期为加强我国药品上市后研究提供参考。 Study on post-marketing drug have becomed an extensive focu. Introduced the limitations of pro-marketing drug, the variety and complexity and irrationality of drug usage, the analysis of study on post-marketing drug in domestic or overseas. Provide references for strengthening the development of our study on post-marketing drug.
作者 杨乐 吴晔
出处 《中国药物警戒》 2007年第5期265-267,共3页 Chinese Journal of Pharmacovigilance
关键词 药品上市后研究 study on post-marketing drug
  • 相关文献

参考文献1

二级参考文献8

  • 1[1]Inman WH.Postmarketing surveillance of adverse drug reactions in general practice.II:Prescription-event monitoring at the University of Southampton[J].Br Med J (Clin Res Ed),1981,282(6271):1216-1217.
  • 2[2]Inman WH.Prescription-event monitoring and yellow cards[J].Lancet,1984,1(8389):1301.
  • 3[3]Mann RD.Prescription-event Monitoring.In:Strom BL,ed[M].Pharmacoepidemiology.3rd.Chichester:John Wiley & Sons Ltd,2000,231-246.
  • 4[4]Shakir SW.PEM in the UK.In:Mann RD,ed[M].Pharmacovigilance.Chichester:John Wiley & Sons Ltd,2002,333-344.
  • 5[5]Emerson A,Martin RM,Tomlin M,et al.Prospective cohort study of adverse events monitored by hospital pharmacists.Hospital Adverse Event Monitoring Study (HAEMS) Group[J].Pharmaeoepidemiol Drug Saf,2001,10(2):95-103.
  • 6[6]Coulter DM.PEM in New Zealand.In:Mann RD,ed[M].Pharmacovigilance.Chichester:John Wiley & Sons Ltd,2002,345-362.
  • 7[7]Kubota K.Prescription-event monitoring in Japan (J-PEM)[J].Drug Saf,2002,25(6):441-444.
  • 8[8]Kubota K,Kawabe E,Hinotsu S,et al.Pilot study of prescription-event monitoring in Japan comparing troglitazone with alternative oral hypoglycemics[J].Eur J Clin Pharmacol,2001,56(11):831-838.

共引文献7

同被引文献40

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部